Abbott's XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COM... (information about XIENCE V including imp...)

HOME >> MEDICINE >> TECHNOLOGY

Abbott's XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial

Date:9/23/2009

information about XIENCE V, including important safety information, is available online at www.xiencev.com or www.abbottvascular.com/en_US/content/document/eIFU_XienceV.pdf.

About Abbott Vascular

Abbott Vascular, a division of Abbott, is one of the world's leading vascular care businesses. Abbott Vascular is uniquely focused on advancing the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education. Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Abbotts XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
2. Abbotts XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial
3. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
4. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
5. Abbotts XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
6. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
7. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
8. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
9. SPIRIT II Explores Long-Term Performance of XIENCE V Stent
10. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
11. MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R)

Post Your Comments:

(Date:5/23/2013)... 2013 Echo Pharma Acquisition Limited ("Royalty Pharma") announced ... Acceptance Threshold from 90 percent to 50 percent of ... accordance with the terms of the Revised Offer Document ... Under the terms of the Increased Offer, Royalty ... ELN ) for $12.50 per share in cash. The ...

(Date:5/23/2013)... 2013 Nederland keurt als eerste ... geassocieerd met BPH Astellas Pharma ... Pharma Inc, gebaseerd in Tokyo ... dat het Nederlandse College ter Beoordeling van Geneesmiddelen (CBG) ... De handelsvergunning verleend voor VESOMNI is voor "de ...

(Date:5/22/2013)... LAGUNA HILLS, Calif. , May 22, 2013 /PRNewswire/ ... is developing a medical device that will help alleviate ... preeclampsia. APT,s targeted apheresis cartridge is expected to be ... a leading cause of maternal and fetal death. ... in the United States . It ...

[0] Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share [0] Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen [0] Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia

... YORK, Sept. 16 Reportlinker.com announces that ... in its catalogue: Prosthetic ... Assessment and Market Forecasts to 2016 ... Prosthetic Heart Valves - Global Pipeline Analysis, ...

... MedClean Technologies (OTC Bulletin Board: MCLN ), ... and disposal of medical waste and the destruction of ... signed a distribution agreement with Trojan Energy Systems, Inc., ... years of combined experience in the sale and service ...

Cached Medicine Technology:Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2 Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3 MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems 2 MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems 3

Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems

(Date:5/23/2013)... 23, 2013) Aortic arch pulse wave velocity, a ... of disease of the vessels that supply blood to ... the June issue the journal Radiology . ... functional information about vessel compliance that may help determine ... said Kevin S. King, M.D., assistant professor of radiology ...

(Date:5/23/2013)... (PRWEB) May 23, 2013 Applied PilotFish ... announced today that it has added support for the ... IDE, the eiConsole for Healthcare. In addition to the ... as LLP, FTP, and Web Services, it now offers ... Direct Protocol is a specification of the Direct ...

(Date:5/23/2013)... Elegance for a woman takes on so many ... her intrigue can often be found in the mystery of her ... soul is through her eyes. It is also true that ... is why the elegance of a woman can be found in ... more than any other time, utilize eyewear to not only compliment ...

(Date:5/23/2013)... Aero Fulfillment Services, a national provider of ... to be the sole fulfillment provider for Olivenol® plus ... Brad Cole, CEO New Wave Biosciences said, “We chose ... location, e-commerce experience with both of our key audiences ... that will expand as our distribution grows.” He ...

(Date:5/23/2013)... Each month Dwell magazine is filled with ... electric cars. Nowhere in America are these pages more scoured ... capital. Thankfully this June, Green Car Journal is bringing its ... Dwell on Design 2013 ( http://www.dwellondesign.com ), America’s ... days of Dwell on Design, June 21-22, attendees and media ...

Breaking Medicine News(10 mins):Health News:MRI-based measurement helps predict vascular disease in the brain 2 Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2 Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2 Health News:NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation 2 Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2 Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3 Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4 Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5

[0] MRI-based measurement helps predict vascular disease in the brain [0] PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release [0] Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc.[0] NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation [0] Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013

... the lymph nodes also, according to a recent research, led ... immune response. // ,The dreaded disease is ... and the immature parasites travel to the animal's liver. Once ... liver cells and infect red blood cells, beginning the onset ...

... the teenaged girls in the UK are virtually starving themselves to ... Agency and Sugar magazine. // Some of these girls are reported ... 50 per cent always skip breakfast and do not know what ... they eat ‘as little as possible,’ while ten per cent said ...

... risk factors like blood pressure, age and medical history. Those who ... can be treated as outpatients, according to a publication in ... abrupt blockage of an artery due to a blood clot, or ... major health hazard. This is not fatal in the case of ...

... many as 20% of the men in the US suffer ... other diseases, including heart diseases. // The number of visits ... was introduced in 1998. The data available from the National ... S. Saigal and his colleagues. ,About 2,126 men ...

... that as many as 250,000 Scots are unable to access ... Health Department had drawn up an emergency care plan which ... as ?1.5 million has been allocated for this. The situation ... 10% of the population having to wait for a period ...

... a survey in 5 European countries on how women lead ... to find out whether women enjoyed the present life ... the work was funded by Economic and Social Research Council. ... have problems with their family life. ,Researchers found ...

Cached Medicine News:Health News:Malaria Can Develop In Lymph Nodes Also 2

Malaria Can Develop In Lymph Nodes Also Half The Girls In UK Starve To Stay Slim Risk Factors Can Identify Pulmonary Embolism Erectile Dysfunction Connected To Heart Disease Scots Do Not Have Access To Proper Dental Care Can Women strike a balance between work and domestic life?

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

Nitrazepam, Serum or Plasma Nipple Discharge for Cytology Nicotine & Metabolites, Serum or Plasma Ni, Urine